Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 3 , Pages 427-441 , June 2010

Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease

  • Zhong Yang, PhD

      Affiliations

    • Key Laboratory of Nanopharmacology and Nanotoxicology, Beijing Institute of Pharmacology and Toxicology, Beijing, China
    • ,
  • Yingge Zhang, PhD, MD

      Affiliations

    • Key Laboratory of Nanopharmacology and Nanotoxicology, Beijing Institute of Pharmacology and Toxicology, Beijing, China
    • Corresponding Author InformationCorresponding authors: 27 Taiping Road, Beijing 100850, China.
    • ,
  • Yanlian Yang, PhD

      Affiliations

    • National Center for Nanoscience and Nanotechnology, Beijing, China
    • ,
  • Lan Sun, PhD

      Affiliations

    • Key Laboratory of Nanopharmacology and Nanotoxicology, Beijing Institute of Pharmacology and Toxicology, Beijing, China
    • ,
  • Dong Han, PhD

      Affiliations

    • National Center for Nanoscience and Nanotechnology, Beijing, China
    • ,
  • Hong Li, PhD

      Affiliations

    • Key Laboratory of Nanopharmacology and Nanotoxicology, Beijing Institute of Pharmacology and Toxicology, Beijing, China
    • ,
  • Chen Wang, PhD, MD

      Affiliations

    • National Center for Nanoscience and Nanotechnology, Beijing, China

Received 20 August 2009 ,Accepted 18 November 2009.

References 

  1. Porter AE, Gass M, Muller K, Skepper JN, Midgley P, Welland M. Direct imaging of single-walled carbon nanotubes in cells. Nat Nanotechnol. 2007;2:713–717
  2. Tanaka M, Nishigaki Y, Fuku N, Ibi T, Sahashi K, Koga Y. Therapeutic potential of pyruvate therapy for mitochondrial diseases. Mitochondria. 2007;7:399–403
  3. Kostarelos K, Lacerda L, Pastorin G, Wu W, Wieckowski S, Luangsivilay J, et al. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat Nanotechnol. 2007;2:108–113
  4. Pantarotto D, Briand JP, Prato M, Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun. 2004;2004:16–17
  5. Pantarotto D, Singh R, McCarthy D, Erhardt M, Briand J-P, Prato M, et al. Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew Chem Int Edn. 2004;43:5242–5246
  6. Cai D, Jennifer MM, Qin Z-H, Huang Z, Huang J, Chiles TC, et al. Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nat Methods. 2005;2:449–454
  7. Gao L, Nie L, Wan T, Qin Y, Guo Z, Yang D, et al. Carbon nanotube delivery of the GFP gene into mammalian cells. Chem BioChem. 2006;7:239–242
  8. Liu Y, Wu D-C, Zhang W-D, Jiang X, He C-B, Chung T-S, et al. Polyethylenimine-grafted multiwalled carbon nanotubes for secure noncovalent immobilization and efficient delivery of DNA. Angew Chem Int Edn Eng. 2005;44:4782–4785
  9. Kam NWS, Dai HJ. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc. 2005;127:6021–6026
  10. Cherukuri P, Bachilo S, Litovsky S, Weisman R. Near-infrared fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells. J Am Chem Soc. 2004;126:15638–15639
  11. Rouse JG, Yang J, Barron AR, Monteiro-Riviere NA. Fullerene-based amino acid nanoparticle interactions with human epidermal keratinocytes. Toxicol In Vitro. 2006;20:1313–1320
  12. Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YY, Riviere JE. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett. 2005;155:377–384
  13. Shvedova AA, Castranova V, Kisin ER, Schwegler-Berry D, Murray AR, Gandelsman VZ, et al. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A. 2003;66:1909–1926
  14. Bottini M, Bruckner S, Nika K, Bottini N, Bellucci S, Magrini A, et al. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol Lett. 2006;160:121–126
  15. Cui D, Tian F, Ozkan CS, Wang M, Gao H. Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett. 2005;155:73–85
  16. Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci. 2004;77:126–134
  17. Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol. 2005;207:221–231
  18. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol. 2005;289:L698–708
  19. Heller D, Baik S, Eurell T, Strano M. Single-walled carbon nanotube spectroscopy in live cells: towards long-term labels and optical sensors. Adv Mater. 2005;17:2793–2799
  20. Sato Y, Yokoyama A, Shibata K, Akimoto Y, Ogino S, Nodasaka Y, et al. Influence of length on cytotoxicity of multi-walled carbon nanotubes against human acute monocytic leukemia cell line THP-1 in vitro and subcutaneous tissue of rats in vivo. Mol Biosyst. 2005;1:176–182
  21. Albini A, Mussi V, Parodi A, Ventura A, Principi E, Tegami SM, et al. Interactions of single-wall carbon nanotubes with endothelial cells. Nanomedicine. 2010;6:277–288
  22. Fraczek A, Menaszek E, Paluszkiewicz C, Blazewicz M. Comparative in vivo biocompatibility study of single- and multi-wall carbon nanotubes. Acta Biomater. 2008;4:1593–1602
  23. Amatore C, Arbault S, Cristhina D, Ferreira M, Tapsoba I, Verchier Y, et al. stimulates or attenuates reactive oxygen and nitrogen species (ROS, RNS) production depending on cell state: quantitative amperometric measurements of oxidative bursts at PLB-985 and RAW 264.7 cells at the single cell level. J Electroanal Chem. 2008;615:34–44
  24. Smart SK, Cassady AI, Lu GQ, Martin DJ. The biocompatibility of carbon nanotubes. Carbon. 2006;44:1034–1047
  25. Kagan VE, Tyurina YY, Tyurin VA, Konduru NV, Potapovich AI, Osipov AN, et al. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron. Toxicol Lett. 2006;165:88–100
  26. Garza KM, Soto KF, Murr LE. Cytotoxicity and reactive oxygen species generation from aggregated carbon and carbonaceous nanoparticulate materials. Int J Nanomed. 2008;3:83–94
  27. Lacerda L, Soundararajan A, Pastorin G, Al-Jamal KT, Herrero MA, Bao A, et al. Dynamic imaging of functionalized multi-walled carbon nanotube systemic circulation and urinary excretion. Adv Mater. 2008;20:225–230
  28. Lacerda L, Herrero MA, Venner K, Bianco A, Prato M, Kostarelos K. Carbon-nanotube shape and individualization critical for renal excretion. Small. 2008;4:1130–1132
  29. Liu J, Rinzler AG, Dai HG, Hafner JH, Bradley RKP, Boul J, et al. Fullerene pipes. Science. 1998;280:1253–1256
  30. Doh-Ura K, Iwaki T, Caughey B. Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol. 2000;74:4894–4897
  31. Asumendi A, Morales MC, Alvarez A, Aréchaga J, Pérez-Yarza G. Implication of mitochondria-derived ROS and cardiolipin peroxidation in N-(4-hydroxyphenyl) retinamide-induced apoptosis. Br J Cancer. 2002;86:1951–1956
  32. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate forming lipophilic cation JC-1. Proc Natl Acad Sci USA. 1991;88:3671–3675
  33. Izquierdo LA, Barros DM, Medina JH, Izquierdo I. Novelty enhances retrieval of one-trial avoidance learning in rats 1 or 31 days after training unless the hippocampus is inactivated by different receptor antagonists and enzyme inhibitors. Behav Brain Res. 2000;117:215–220
  34. Dimitrova DS, Getova-Spassova DP. Effects of galantamine and donepezil on active and passive avoidance tests in rats with induced hypoxia. J Pharmacol Sci. 2006;101:199–204
  35. Pothakos K, Kurz MJ, Lau YS. Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration. BMC Neurosci. 2009;10(6):[Epub ahead of print]
  36. Liang Z, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain. J Neurochem. 2007;103:2462–2470
  37. Copenhaver TW, Mielke PW. Quantity analysis: a quantal assay refinement. Biometrics. 1977;33:175–186
  38. Memisoglu-Bilensoy E, Doğan AL, Hincal AA. Cytotoxic evaluation of injectable cyclodextrin nanoparticles. J Pharm Pharmacol. 2006;58:585–589
  39. Seglen PO, Gordon PB. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci USA. 1982;79:1889–1892
  40. Majeski AE, Dice JF. Mechanisms of chaperone-mediated autophagy. Int J Biochem Cell Biol. 2004;36:2435–2444
  41. Kreuter J. Nanoparticles and microparticles for drug and vaccine delivery. J Anat. 1996;189:503–505
  42. Florence AT, Hillery AM, Hussain N, Jani PU. Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J Control Rel. 1995;36:39–46
  43. Johng HM, Yoo JS, Yoon TJ, Shin HS, Lee BC, Lee CH, et al. Use of magnetic nanoparticles to visualize threadlike structures inside lymphatic vessels of rats. eCAM. 2007;4:77–82
  44. Freitas RA. Systematic nanorobot distribution and phagocytosis. In:  Freitas RA editors. Nanomedicine. Biocompatibility. vol. IIA:Austin (Tex): Landes Bioscience; 2003;p. 93–154
  45. Varshosaz J. pH-sensitive polymers for cytoplasmic drug delivery. Expert Opin Ther Patents. 2008;18:959–962
  46. Heffernan MJ, Murth N. Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle. Bioconjug Chem. 2005;16:1340–1342
  47. Bae Y, Fukushima S, Harada A, Kataoka K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew Chem Int Ed Eng. 2008;4640-3:42
  48. Benzi G, Moretti A. Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radic Biol Med. 1995;19:77–101
  49. Vartanian LS, Gurevich SM. Effect of ionol on superoxide radical metabolism in murine liver. Vopr Med Khim. 1999;45:314–320
  50. Polla BS, Kantengwa S, Francois D, Salvioli S, Franceschi C, Marsac C, et al. Mitochondria are selective targets for the protective effects of heat shock against oxidative injury. Proc Natl Acad Sci USA. 1996;93:6458–6463
  51. Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria in cancer cells: what is so special about them?. Trends Cell Biol. 2008;18:165–173
  52. Herholz K. Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2008;35(Suppl 1):S25–S29
  53. Razay G, Wilcock GK. Galantamine in Alzheimer's disease. Expert Rev Neurother. 2008;8:9–17
  54. Lu J. Effect of surface modifications on the decoration of multi-walled carbon nanotubes with ruthenium nanoparticles. Carbon. 2007;45:1599–1605
  55. Takenaka S, Arike T, Nakagawa K, Matsune H, Kishida M, Tanabe E. Synthesis of carbon nanotube-supported Pt nanoparticles covered with silica layers. Carbon. 2008;46:365–368
  56. Mota JPB, Esteves IAAC. Simplified gauge-cell method and its application to the study of capillary phase transition of propane in carbon nanotubes. Adsorption. 2007;13:21–32
  57. Sun ML, Cheng RM, Xu XC, Chen YW, Li MG. Studies on adsorption of phenol and substituted phenols on carbon nanotubes. Chem Res Appl. 2006;18:13–16
  58. Murugesan S, Xie J, Linhardt RJ. Immobilization of heparin: approaches and applications. Curr Top Med Chem. 2008;8:80–100
  59. Kane RS, Stroock AD. Nanobiotechnology: protein-nanomaterial interactions. Biotechnol Prog. 2007;23:316–319
  60. Zhao M, Brunk UT, Eaton JW. Delayed oxidant-induced cell death involves activation of phospholipase A2. FEBS Lett. 2001;509:399–404

 This work was supported by National Basic Research Program of China (2006CB933304, 2006CB705602-7, and 2010CB933904).

PII: S1549-9634(09)00339-6

doi: 10.1016/j.nano.2009.11.007

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 3 , Pages 427-441 , June 2010

Article Tools

* Image Usage & Resolution